HomeNVTA • BMV
Follow
Invitae Corporation
Previous close
$0.23
Year range
$6.05 - $28.94
Market cap
3.72M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
.INX
0.019%
.INX
0.019%
0.035%
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 121.24M | -9.21% |
Operating expense | 141.95M | -21.71% |
Net income | -942.11M | -212.83% |
Net profit margin | -777.05 | -244.56% |
Earnings per share | -0.10 | 76.19% |
EBITDA | -71.16M | 42.73% |
Effective tax rate | 0.65% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 254.57M | -56.55% |
Total assets | 535.12M | -73.59% |
Total liabilities | 1.62B | -13.33% |
Total equity | -1.08B | — |
Shares outstanding | 286.49M | — |
Price to book | -0.06 | — |
Return on assets | -25.00% | — |
Return on capital | -28.48% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -942.11M | -212.83% |
Cash from operations | -66.90M | 48.02% |
Cash from investing | 5.12M | -88.32% |
Cash from financing | -3.38M | -99.94% |
Net change in cash | -65.16M | 24.76% |
Free cash flow | -29.46M | -38.14% |
About
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012.
In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million. Wikipedia
Founded
2010
Headquarters
Website
Employees
1,700